Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder
PHASE4Not yet recruitingINTERVENTIONAL
Enrollment
246
Participants
Timeline
Start Date
June 30, 2026
Primary Completion Date
July 31, 2029
Study Completion Date
December 31, 2029
Conditions
Major Depressive Disorder
Interventions
DRUG
bupropion hydrobromide
study drug
DRUG
Placebo
placebo arm
All Listed Sponsors
lead
Bausch Health Americas, Inc.
INDUSTRY
NCT02129751 - Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder | Biotech Hunter | Biotech Hunter